AB&B BIO-TECH-B (02627) has announced the appointment of Ms. Le Meijia as an Independent Non-Executive Director of the second-term Board of Directors and a member of the Board's Audit Committee, effective from May 27, 2026. Additionally, Bai Chun has been appointed as the company's new auditor. The auditor's term will commence upon the conclusion of the extraordinary general meeting on May 27, 2026, and will last until the end of the company's next annual general meeting.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments